Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 10—October 2013

Increased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil

Marcio NucciComments to Author , Andrea G. Varon, Marcia Garnica, Tiyomi Akiti, Gloria Barreiros, Beatriz Moritz Trope, and Simone A. Nouér
Author affiliations: University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Main Article


Characteristics of 21 patients with invasive fusariosis in the hematology united at University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 2000–2010*

Characteristic Patients
Sex, M:F 16:5
Median age, y (range)
55 (9–71)
Underlying disease
Acute myeloid leukemia 9 (42.9)
Multiple myeloma 4 (19.0)
Non-Hodgkin lymphoma 2 (9.5)
Acute lymphoid leukemia 2 (9.5)
Myelodysplasia 2 (9.5)
Aplastic anemia 1 (4.8)
Chronic myeloid leukemia
1 (4.8)
HCT recipients 12 (57.1)
Allogeneic 8 (38.1)
4 (19.0)
Room with HEPA filter 14 (66.7)
Receipt of corticosteroids
16 (76.2)
Graft-versus-host disease, n = 8† 6 (75.0)
Neutropenia 17 (81.0)
Skin as portal of entry 17 (81.0)
Positive blood culture
11 (52.4)
Classification of fusariosis
Proven 20 (95.2)
1 (4.8)
Primary treatment
None 1 (4.8)
Voriconazole 7 (33.3)
Deoxycholate amphotericin B 10 (47.6)
Deoxycholate amphotericin B + voriconazole 3 (14.3)

*Values are no. (%) patients except as indicated. HCT, hematopoietic cell transplant; HEPA, high-efficiency particulate air.
†Allogeneic HCT recipients.

Main Article

Page created: September 19, 2013
Page updated: September 19, 2013
Page reviewed: September 19, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.